From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain

Pascal Crépey, Esther Redondo, Javier Díez-Domingo, Raúl Ortiz de Lejarazu, Federico Martinón-Torres, Ángel Gil de Miguel, Juan Luis López-Belmonte, Fabián P Alvarez, Hélène Bricout and Míriam Solozabal

PLOS ONE, 2020, vol. 15, issue 5, 1-19

Abstract: Purpose: Quadrivalent influenza vaccine (QIV) includes the same strains as trivalent influenza vaccine (TIV) plus an additional B strain of the other B lineage. The aim of the study was to analyse the public health and economic impact of replacing TIV with QIV in different scenarios in Spain. Methods: A dynamic transmission model was developed to estimate the number of influenza B cases prevented under TIV and QIV strategies (

Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0233526 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 33526&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0233526

DOI: 10.1371/journal.pone.0233526

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().